Wird geladen...

The Anti-Factor Xa Range For Low Molecular Weight Heparin Thromboprophylaxis

Low molecular weight heparins (LMWHs) are now the mainstay option in the prevention and treatment of venous thromboembolism. In some patients receiving therapeutic doses of LMWH, activity can be measured by quantifying the presence of Anti-factor Xa (AFXa) for dose adjustment. However, currently the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Hematol Rep
Hauptverfasser: Wei, Matthew Y., Ward, Salena M.
Format: Artigo
Sprache:Inglês
Veröffentlicht: PAGEPress Publications, Pavia, Italy 2015
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4691677/
https://ncbi.nlm.nih.gov/pubmed/26733269
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/hr.2015.5844
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!